09 August 2018
The Federal Antimonopoly Service draws the attention of owners or holders of registration certificates of medicines included in the list of vital and essential drugs (VED).
In accordance with the Federal Law No.193-FZ of 03.07.2018 “On Amendments to the Federal Law “On Federal budget for 2018 and for the planning period of 2019 and 2020” from 04.07.2018 the projected inflation rate for the current year has been changed from 4.0% to 2.8%.
This information should be used to prepare documents for the re-registration of the manufacturer’s maximum selling price for medicines included in the list of vital and essential medicines.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024